510(k) device
Neuromonics Tinnitus Treatment
Neuromonics Pty, Ltd. · Masker, Tinnitus (KLW, Class II) · First FDA decision Jan 28, 2005, newest Jan 28, 2005Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Neuromonics"
MAUDE reports
2
Brand "Neuromonics", since 2015
PubMed studies
15
Mentioning "Neuromonics"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Neuromonics Tinnitus Treatment
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K043274 · Decided Jan 28, 2005 · 63 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Neuromonics", any status and sponsor, newest update first.
- Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind StudyPivotal-lookingStatus unknown
United States Army Aeromedical Research LaboratoryFederal agency
NCT02829073 · 120 participants (planned) · Start Apr 2016 · Primary completion Dec 2017
Device: Neuromonics Tinnitus Treatment Program; Placebo Device · For: Tinnitus
Sites: Fort Rucker, Alabama
- Customized Acoustic Stimulation for Long Term Medical Benefit for the Relief of Tinnitus and HyperacusisStatus unknown
Neuromonics, Inc.Not on our public-company list
NCT00730834 · 53 participants · Start Jun 2007 · Primary completion Dec 2010
Device: Oasis · For: Tinnitus; Hyperacusis
Sites: Sarasota, Florida
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Neuromonics", and for the whole product code for context.
This brand
2 reports: 1 malfunction, 1 injury, 0 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- NEUROMONICS OASIS TINNITUS DEVICEMalfunction
MW5044715 · Received Jul 17, 2015 · Event dated May 26, 2015
Device type: Masker, Tinnitus (KLW)
Device problem as coded: Device Operates Differently Than Expected; Therapeutic or Diagnostic Output Failure
Patient problem as coded: Tinnitus
- NEUROMONICS OASISInjury
MW5040884 · Received Feb 20, 2015 · Event dated Jan 1, 2014
Device type: Masker, Tinnitus (KLW)
Device problem as coded: Device Operates Differently Than Expected
Patient problem as coded: Hearing Impairment
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Neuromonics"[tiab]. The summary above synthesizes these.
- Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study.
Davis PB, Wilde RA, Steed LG, et al. · Ear Nose Throat J · 2008Comparative Study, Controlled Clinical Trial
- Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice.
Hanley PJ, Davis PB, Paki B, et al. · Ann Otol Rhinol Laryngol · 2008Comparative Study, Controlled Clinical Trial
- Neuromonics Tinnitus Treatment: third clinical trial.
Davis PB, Paki B, Hanley PJ · Ear Hear · 2007Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Systematic Review on Healthcare and Societal Costs of Tinnitus.
Trochidis I, Lugo A, Borroni E, et al. · Int J Environ Res Public Health · 2021Research Support, Non-U.S. Gov't, Systematic Review
- Evaluation of a customized acoustical stimulus system in the treatment of chronic tinnitus.
Wazen JJ, Daugherty J, Pinsky K, et al. · Otol Neurotol · 2011Research Support, Non-U.S. Gov't
- Tinnitus: current understanding and contemporary management.
Seidman MD, Standring RT, Dornhoffer JL · Curr Opin Otolaryngol Head Neck Surg · 2010Review
- A multi-centre study on the long-term benefits of tinnitus management using Neuromonics Tinnitus Treatment.
Vieira D, Eikelboom R, Ivey G, et al. · Int Tinnitus J · 2011Clinical Trial, Multicenter Study
- Recent experience with the neuromonics tinnitus treatment.
Goddard JC, Berliner K, Luxford WM · Int Tinnitus J · 2009
- Neuromonicsࡊ Tinnitus Treatment: preliminary experience in a private practice setting.
Jang DW, Johnson E, Chandrasekhar SS · Laryngoscope · 2010
- A Scoping New Revolution for Tinnitus Management: A Neuromonics Narrative Review.
Gupta J, Gupta R · Curr Drug Targets · 2023Review
- Recent technological advances in sound-based approaches to tinnitus treatment: a review of efficacy considered against putative physiological mechanisms.
Hoare DJ, Adjamian P, Sereda M, et al. · Noise Health · 2013Research Support, Non-U.S. Gov't, Review
- Using therapeutic sound with progressive audiologic tinnitus management.
Henry JA, Zaugg TL, Myers PJ, et al. · Trends Amplif · 2008Research Support, U.S. Gov't, Non-P.H.S.
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 510(k) 2026
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.